These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 18482529)

  • 1. [Endocannabinoid system: new perspectives in the global management of cardiometabolic risk factors].
    Maldonado R
    Med Clin (Barc); 2008 May; 130(16):615-22. PubMed ID: 18482529
    [No Abstract]   [Full Text] [Related]  

  • 2. [The endocannabinoid system].
    Sudano I; Périat D; Noll G
    Praxis (Bern 1994); 2008 Apr; 97(7):375-80. PubMed ID: 18548817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Endocannabinoid system and energy metabolism: physiology and pathophysiology].
    Pagotto U; Vicennati V; Pasquali R
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):74S-82S. PubMed ID: 18773754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substantially altered expression pattern of cannabinoid receptor 2 and activated endocannabinoid system in patients with severe heart failure.
    Weis F; Beiras-Fernandez A; Sodian R; Kaczmarek I; Reichart B; Beiras A; Schelling G; Kreth S
    J Mol Cell Cardiol; 2010 Jun; 48(6):1187-93. PubMed ID: 19931541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The endocannabinoid system: a new perspective for cardiometabolic risk control.
    Francischetti EA; de Abreu VG
    Arq Bras Cardiol; 2006 Oct; 87(4):548-58. PubMed ID: 17128328
    [No Abstract]   [Full Text] [Related]  

  • 6. The endocannabinoid-CB receptor system: Importance for development and in pediatric disease.
    Fride E
    Neuro Endocrinol Lett; 2004; 25(1-2):24-30. PubMed ID: 15159678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of activation of endocannabinoid system on myocardial metabolism.
    Polak A; Harasim E; Chabowski A
    Postepy Hig Med Dosw (Online); 2016 May; 70(0):542-55. PubMed ID: 27333924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacotherapeutic targeting of the endocannabinoid signaling system: drugs for obesity and the metabolic syndrome.
    Vemuri VK; Janero DR; Makriyannis A
    Physiol Behav; 2008 Mar; 93(4-5):671-86. PubMed ID: 18155257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The endocannabinoid receptor, CB1, is required for normal axonal growth and fasciculation.
    Watson S; Chambers D; Hobbs C; Doherty P; Graham A
    Mol Cell Neurosci; 2008 May; 38(1):89-97. PubMed ID: 18378465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2-Arachidonylglycerol acting on CB1 cannabinoid receptors mediates delayed cardioprotection induced by nitric oxide in rat isolated hearts.
    Wagner JA; Abesser M; Harvey-White J; Ertl G
    J Cardiovasc Pharmacol; 2006 May; 47(5):650-5. PubMed ID: 16775503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The endocannabinoid system: a new target for the regulation of energy balance and metabolism.
    Després JP
    Crit Pathw Cardiol; 2007 Jun; 6(2):46-50. PubMed ID: 17667864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Important Role of the Endocannabinoid System and the Endocannabinoidome in Gut Health.
    Meletis C
    Altern Ther Health Med; 2019 Jun; 25(S2):24-28. PubMed ID: 31202201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The brain endocannabinoid system in the regulation of energy balance.
    Richard D; Guesdon B; Timofeeva E
    Best Pract Res Clin Endocrinol Metab; 2009 Feb; 23(1):17-32. PubMed ID: 19285258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the endocannabinoid system in energy balance regulation and obesity.
    Cota D
    Front Horm Res; 2008; 36():135-145. PubMed ID: 18230900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of the endocannabinoid system for the reduction of cardiometabolic risk factors.
    Samaha FF; Chou CM
    Obesity (Silver Spring); 2009 Feb; 17(2):220-5. PubMed ID: 19039319
    [No Abstract]   [Full Text] [Related]  

  • 16. [Endocannabinoid system and bowel inflammation].
    Márquez L; Abanades S; Andreu M
    Med Clin (Barc); 2008 Oct; 131(13):513-7. PubMed ID: 19007582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocannabinoid system and fear conditioning.
    Resstel LB; Moreira FA; Guimarães FS
    Vitam Horm; 2009; 81():421-40. PubMed ID: 19647121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabinoid receptors and endocannabinoids: evidence for new players.
    Mackie K; Stella N
    AAPS J; 2006 Apr; 8(2):E298-306. PubMed ID: 16796380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocannabinoid system and cardiometabolic risk.
    Saavedra LE
    Clin Pharmacol Ther; 2007 Nov; 82(5):591-4. PubMed ID: 17898706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pretreatment with electroacupuncture induces rapid tolerance to focal cerebral ischemia through regulation of endocannabinoid system.
    Wang Q; Peng Y; Chen S; Gou X; Hu B; Du J; Lu Y; Xiong L
    Stroke; 2009 Jun; 40(6):2157-64. PubMed ID: 19372445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.